Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Operating Expenses: 2020-2024

Historic Operating Expenses for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $205.4 million.

  • Prime Medicine's Operating Expenses rose 1.39% to $55.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.9 million, marking a year-over-year decrease of 7.55%. This contributed to the annual value of $205.4 million for FY2024, which is 0.32% up from last year.
  • Prime Medicine's Operating Expenses amounted to $205.4 million in FY2024, which was up 0.32% from $204.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Operating Expenses ranged from a high of $205.4 million in FY2024 and a low of $6.1 million during FY2020.
  • Its 3-year average for Operating Expenses is $175.6 million, with a median of $204.8 million in 2023.
  • Data for Prime Medicine's Operating Expenses shows a peak YoY soared of 1,275.35% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Prime Medicine's Operating Expenses stood at $6.1 million in 2020, then soared by 1,275.35% to $84.5 million in 2021, then surged by 37.96% to $116.5 million in 2022, then surged by 75.72% to $204.8 million in 2023, then climbed by 0.32% to $205.4 million in 2024.